Hal H. Simeroth, Ph.D. is the co-founder and Chief Technical Officer for Stemology, also acting as lead formulator for the Stemology product line. Dr. Simeroth has been performing research and product development in skin science over the past twelve years. During this time, he has consulted for, or worked for, four skin care companies, and designed a number of skin care product lines, which includes the latest Stemology product line. Through this twelve-year period Dr. Simeroth has focused his research on the application of stem cell technology in skin care and continues to do so. His work in formulation led to the initiation and use of a new complex of ingredients that, when combined with growth enhancing ingredients, derived in part from the most advanced stem cell research and technologies, enable the formulated combination of ingredients to enhance, more effectively, the body’s natural “call to repair” response. These unique, growth-enhancing secretions, along with the concomitant performance-enhancing ingredients, are uniquely designed for use in Stemology anti-aging skin care products.
An expert research scientist and research engineer, Dr. Simeroth’s career has spanned more than forty years including experience at both the scientific researcher level and at the director and Vice President of Research level. From June 2004, to June 2008, Dr. Simeroth managed three research projects, all with a focus in biochemistry. At the State University of New York – Buffalo, he helped develop university research patents into a unique cellular identification methodology for detecting molecular level biochemicals. At the University of Texas, Austin he managed a corporate-sponsored research project, which led to a unique bacterial fabrication for use as artificial skin for burn victims. And in cooperation with the University of Dayton research labs, he directed a team developing a unique chemical sensing device.
Dr. Simeroth also, over a previous twenty-year period, has served as Vice President of Research and Development for four large public companies: Eagle Technologies, MSI Data Corporation, Encad Corporation, and Symbol Technologies.
Dr. Simeroth received his Ph.D. in ethics, with a focus in bioethics, from the University of Southern California (USC). Prior to that he completed studies in the Master of Science Engineering Graduate Program of California State University, Fullerton, plus management studies at California Institute of Technology (Cal Tech), and also attended a special research graduate program at the Massachusetts Institute of Technology (MIT). Dr. Simeroth received his Bachelor of Science degree in Engineering from California State University, Long Beach. He currently resides in Dana Point, Calif.